McKesson | MCK - Gross Profit On Sales

Stock Price
870.66
Daily Change
14.04 1.64%
Monthly
-7.59%
Yearly
29.61%
Q2 Forecast
857.66

McKesson reported $3.68B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Acadia Healthcare USD 821.16M 19.54M Sep/2025
Align Technology USD 683.59M 44.39M Dec/2025
Cardinal Health USD 2.4B 78M Dec/2025
Centene USD 2.14B 796M Dec/2025
Charles River Laboratories USD 271.96M 39.43M Dec/2025
Cigna USD 56.45B 50.29B Sep/2025
Community Health Systems USD 2.76B 70M Dec/2024
Computer Programs Systems USD 35.62M 3.23M Dec/2025
CVS Health USD 13.57B 239M Dec/2025
DaVita Healthcare Partners USD 1.02B 63.9M Dec/2025
Dentsply International USD 443M 2M Dec/2025
eHealth USD -42.47M 14.5M Sep/2024
Elevance Health USD 11.68B 889M Dec/2025
Encompass Health USD 1.41B 786M Sep/2025
HCA USD 8.18B 161M Dec/2025
Henry Schein USD 1.06B 37M Dec/2025
Humana USD 4.82B 754M Jun/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
J&J USD 16.6B 118M Dec/2025
Laboratory Of America USD 993.2M 31.9M Dec/2025
McKesson USD 3.68B 143M Dec/2025
Molina Healthcare USD 1.2B 193M Dec/2025
Owens Minor USD 272.05M 20.92M Dec/2025
Quest Diagnostics USD 873M 37M Dec/2025
Stryker USD 4.49B 633M Dec/2025
Tenet Healthcare USD 2.22B 22M Sep/2025
UnitedHealth USD 20.64B 77.96B Sep/2025
Universal Health Services USD 2.01B 158.68M Sep/2025
Veradigm USD 83.44M 3.95M Sep/2022